Grant Krafft

Dr. Grant Krafft is a co-founder of Acumen and currently serves as Chief Scientific Adviser and Chairman of the Board of Directors.Dr. Krafft was formally Acumen’s Chief Scientific Officer. Prior to Acumen, Dr. Krafft was Research Professor of Molecular Pharmacology and Biological Chemistry at Northwestern University Medical School, where he and his colleagues discovered Amyloid-beta Derived Dementing Ligands (ADDLs). Dr. Krafft also served as Director of Research Development for the ENH Research Institute, a Northwestern University Medical School affiliate. Previously, Dr. Krafft was Chief Technical Officer of Tibotec-Virco, a HIV therapeutics and pharmacogenomics company, and a Volwiler Research Fellow at Abbott Laboratories in its Diagnostics and Pharmaceutical Products Divisions. Dr. Krafft holds a B.S. in Chemistry from Valparaiso University, and a Ph.D. in Organic Chemistry from the University of Illinois, Urbana-Champaign, and was a NIH post-doctoral fellow at the University of Wisconsin, Madison.